Cancer-Specific Survival Following Surgery


Our ovarian cancer nomogram is a tool designed to predict the likelihood of surviving ovarian cancer for five years after surgical treatment for the disease. It is appropriate for patients with any stage of epithelial ovarian cancer who have had surgery (also called debulking or cytoreductive surgery) to remove as much of the cancer as possible.

Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of ovarian cancer procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.

To gather the information required to use this nomogram, use our worksheet.

Enter Your Information

All fields are required unless noted optional
years (20 to 100)
Note: This prediction tool was created using the 1986 FIGO staging system; it applies to stages I to IV. If your pathology report uses a later version with stages that are not included in this drop-down menu, consult with your physician for further guidance on selecting the correct stage.
More on FIGO staging
The FIGO staging system, developed by the International Federation of Gynecology and Obstetrics (FIGO), is used to stage cancers of the cervix, uterus, ovary, vagina, and vulva. It is based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.
g/dl (1.5 to 5.5)
What is albumin?
Albumin is a protein made by the liver. A serum albumin test measures the level of albumin in the blood.
What is debulking?
Debulking refers to the surgical removal of as much of a tumor as possible. Also called tumor debulking.
What is histology?
Histology refers to the exact type of cancer based on examination of the tumor tissue under the microscope.
What is ASA score?
The ASA score refers to the American Society of Anesthesiologists (ASA) physical status classification system that is used to grade the preoperative physical health of patients who are undergoing surgery.
Do you have a family history suggestive of hereditary breast/ovarian cancer (HBOC) syndrome?
Note: For patients with a Jewish background, select “yes” if you have a personal or family history of breast cancer, or family history of ovarian cancer. For other patients, select “yes” if you have a personal history of breast cancer, family history of breast cancer before age 50, or ovarian cancer at any age.
What is HBOC syndrome?
Hereditary breast/ovarian cancer (HBOC) syndrome refers to an inherited disorder in which the risk of breast cancer (especially before the age of 50) and ovarian cancer is higher than normal. Most cases of HBOC syndrome are caused by certain mutations (changes) in the BRCA1 or the BRCA2 gene.